DJIA 18,053.71 23.50 0.13%
NASDAQ 4,806.86 33.39 0.70%
S&P 500 2,088.77 6.89 0.33%
market minute promo

Myriad Genetics (NASDAQ: MYGN)

36.65 0.15 (0.41%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MYGN $36.65 0.41%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $36.66
Previous Close $36.50
Daily Range $36.53 - $37.41
52-Week Range $20.02 - $42.50
Market Cap $2.7B
P/E Ratio 20.51
Dividend (Yield) $0.00 (0.0%)
Volume 285,947
Average Daily Volume 715,108
Current FY EPS $1.84




Diversified Services

Myriad Genetics (MYGN) Description

Myriad Genetics is focused on developing and marketing novel molecular diagnostic products. Website:

News & Commentary Rss Feed

3 Stocks Even Volatility-Loving Nasdaq Investors Hate

The Nasdaq Composite may be hitting a multidecade high, but pessimists are piling into these three Nasdaq-listed stocks. Are things really as bad as these short-interest figures indicate?

Update: Myriad Genetics Won FDA Approval For BRACAnalysis CDx

Myriad Genetics' Ovarian Cancer Test Wins FDA Approval - Analyst Blog

Myriad Genetics' Ovarian Cancer Test Wins FDA Approval - Analyst Blog

Will myRisk Cancer Test Work Wonders for Myriad Genetics? - Analyst Blog

Myriad Genetics Breaks Above 200-Day Moving Average - Bullish for MYGN

Genomic Health's Oncotype DX Positive in Multiple Studies - Analyst Blog

Where Are They Now? A Look Back at the Best & Worst Biotech CEOs

A Closer Look At 5 Heavily Shorted Stocks

Myriad Genetics Unveils Positive Cancer Study Results - Analyst Blog

Genomic Health's Oncotype DX: Cancer Testing Made Easier - Analyst Blog

Myriad Genetics' Prolaris: A Pocket-Friendly Cancer Test - Analyst Blog

See More MYGN News...

MYGN's Top Competitors

MYGN $36.65 (0.41%)
Current stock: MYGN
AMGN $163.46 (1.74%)
Current stock: AMGN
GILD $93.79 (2.74%)
Current stock: GILD
BIIB $342.40 (0.44%)
Current stock: BIIB